RenovoRx, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
RNXT on Nasdaq
Industry
Pharmaceutical Preparations
Location
2570 W. El Camino Real, Ste. 320,, Mountain View, CA

Insiders trading volume in the past year

RenovoRx, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Kamran Najmabadi 10%+ Owner $1.03M Aug 25, 2021
Ramtin Agah Chief Medical Officer, Director $1.03M +$105K +11.4% Jul 1, 2025
Bank Of The West 10%+ Owner $1.02M Mar 16, 2022
Shaun Bagai Chief Executive Officer, Director $300K +$32.7K +12.2% Aug 22, 2025
Paul Manners Chief Financial Officer $24.4K Aug 25, 2021
Ron Kocak VP, Controller and PAO $9.95K +$10K Jul 1, 2025
Laurence Marton Director $9.92K +$10.2K Oct 1, 2025
Angela Nelms Chief Operating Officer $1.15K Jan 19, 2024
Christopher J. Lehman Chief Financial Officer Aug 30, 2021
James M. Ahlers Chief Financial Officer Jul 15, 2022
Una S. Ryan Director Oct 1, 2025
Leesa Gentry Chief Clinical Officer Jul 1, 2025
David Diamond Director Oct 1, 2023
Robert J. Spiegel Director Oct 1, 2025
K. Angela Macfarlane Director Oct 1, 2025

Recent Insider Transactions by Companies or Individuals for RenovoRx, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.